Task: Answer the multiple-choice question.
Question: Which compound exhibits a -0.287\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CC(NC(=O)CCN1N=C(c2ccccc2)CCC1=O)c1ccc2c(c1)OCCO2
b. Cc1cc(C)n2nc(C(=O)N/N=C/c3cccc(Cl)c3)nc2n1
Answer: b. Cc1cc(C)n2nc(C(=O)N/N=C/c3cccc(Cl)c3)nc2n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n2nc(C(=O)N/N=C/c3cccc(Cl)c3)nc2n1
Cc1cc(C)n2nc(C(=O)N/N=C/c3cccc(Cl)c3)nc2n1
N-[(E)-(3-chlorophenyl)methylideneamino]-5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxamide